433 related articles for article (PubMed ID: 19117993)
21. CRL4-DCAF8L2 E3 ligase promotes ubiquitination and degradation of BARD1.
Deng J; Zhang T; Liu F; Han Q; Li Q; Guo X; Ma Y; Li L; Shao G
Biochem Biophys Res Commun; 2022 Jun; 611():107-113. PubMed ID: 35487060
[TBL] [Abstract][Full Text] [Related]
22. Ubiquitination and proteasomal degradation of the BRCA1 tumor suppressor is regulated during cell cycle progression.
Choudhury AD; Xu H; Baer R
J Biol Chem; 2004 Aug; 279(32):33909-18. PubMed ID: 15166217
[TBL] [Abstract][Full Text] [Related]
23. Distinct roles of BARD1 isoforms in mitosis: full-length BARD1 mediates Aurora B degradation, cancer-associated BARD1beta scaffolds Aurora B and BRCA2.
Ryser S; Dizin E; Jefford CE; Delaval B; Gagos S; Christodoulidou A; Krause KH; Birnbaum D; Irminger-Finger I
Cancer Res; 2009 Feb; 69(3):1125-34. PubMed ID: 19176389
[TBL] [Abstract][Full Text] [Related]
24. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.
Jensen DE; Proctor M; Marquis ST; Gardner HP; Ha SI; Chodosh LA; Ishov AM; Tommerup N; Vissing H; Sekido Y; Minna J; Borodovsky A; Schultz DC; Wilkinson KD; Maul GG; Barlev N; Berger SL; Prendergast GC; Rauscher FJ
Oncogene; 1998 Mar; 16(9):1097-112. PubMed ID: 9528852
[TBL] [Abstract][Full Text] [Related]
25. Ubiquitination and proteasome-mediated degradation of BRCA1 and BARD1 during steroidogenesis in human ovarian granulosa cells.
Lu Y; Amleh A; Sun J; Jin X; McCullough SD; Baer R; Ren D; Li R; Hu Y
Mol Endocrinol; 2007 Mar; 21(3):651-63. PubMed ID: 17185394
[TBL] [Abstract][Full Text] [Related]
26. mRNA Processing Factor CstF-50 and Ubiquitin Escort Factor p97 Are BRCA1/BARD1 Cofactors Involved in Chromatin Remodeling during the DNA Damage Response.
Fonseca D; Baquero J; Murphy MR; Aruggoda G; Varriano S; Sapienza C; Mashadova O; Rahman S; Kleiman FE
Mol Cell Biol; 2018 Feb; 38(4):. PubMed ID: 29180510
[TBL] [Abstract][Full Text] [Related]
27. The BRCA1/BARD1 ubiquitin ligase and its substrates.
Witus SR; Stewart MD; Klevit RE
Biochem J; 2021 Sep; 478(18):3467-3483. PubMed ID: 34591954
[TBL] [Abstract][Full Text] [Related]
28. HERC2 is an E3 ligase that targets BRCA1 for degradation.
Wu W; Sato K; Koike A; Nishikawa H; Koizumi H; Venkitaraman AR; Ohta T
Cancer Res; 2010 Aug; 70(15):6384-92. PubMed ID: 20631078
[TBL] [Abstract][Full Text] [Related]
29. The Histone Variant MacroH2A1 Is a BRCA1 Ubiquitin Ligase Substrate.
Kim BJ; Chan DW; Jung SY; Chen Y; Qin J; Wang Y
Cell Rep; 2017 May; 19(9):1758-1766. PubMed ID: 28564596
[TBL] [Abstract][Full Text] [Related]
30. Crucial roles of the BRCA1-BARD1 E3 ubiquitin ligase activity in homology-directed DNA repair.
Wang M; Li W; Tomimatsu N; Yu CH; Ji JH; Alejo S; Witus SR; Alimbetov D; Fitzgerald O; Wu B; Wang Q; Huang Y; Gan Y; Dong F; Kwon Y; Sareddy GR; Curiel TJ; Habib AA; Hromas R; Dos Santos Passos C; Yao T; Ivanov DN; Brzovic PS; Burma S; Klevit RE; Zhao W
Mol Cell; 2023 Oct; 83(20):3679-3691.e8. PubMed ID: 37797621
[TBL] [Abstract][Full Text] [Related]
31. The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin.
Wu-Baer F; Lagrazon K; Yuan W; Baer R
J Biol Chem; 2003 Sep; 278(37):34743-6. PubMed ID: 12890688
[TBL] [Abstract][Full Text] [Related]
32. BRCA1/BARD1 ubiquitinates PCNA in unperturbed conditions to promote continuous DNA synthesis.
Salas-Lloret D; García-Rodríguez N; Soto-Hidalgo E; González-Vinceiro L; Espejo-Serrano C; Giebel L; Mateos-Martín ML; de Ru AH; van Veelen PA; Huertas P; Vertegaal ACO; González-Prieto R
Nat Commun; 2024 May; 15(1):4292. PubMed ID: 38769345
[TBL] [Abstract][Full Text] [Related]
33. Differential modulation of BRCA1 and BARD1 nuclear localisation and foci assembly by DNA damage.
Brodie KM; Henderson BR
Cell Signal; 2010 Feb; 22(2):291-302. PubMed ID: 19796682
[TBL] [Abstract][Full Text] [Related]
34. BRCA1/BARD1 intrinsically disordered regions facilitate chromatin recruitment and ubiquitylation.
Witus SR; Tuttle LM; Li W; Zelter A; Wang M; Kermoade KE; Wilburn DB; Davis TN; Brzovic PS; Zhao W; Klevit RE
EMBO J; 2023 Aug; 42(15):e113565. PubMed ID: 37305927
[TBL] [Abstract][Full Text] [Related]
35. BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.
Fabbro M; Schuechner S; Au WW; Henderson BR
Exp Cell Res; 2004 Aug; 298(2):661-73. PubMed ID: 15265711
[TBL] [Abstract][Full Text] [Related]
36. Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein.
Ayi TC; Tsan JT; Hwang LY; Bowcock AM; Baer R
Oncogene; 1998 Oct; 17(16):2143-8. PubMed ID: 9798686
[TBL] [Abstract][Full Text] [Related]
37. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.
Baer R; Ludwig T
Curr Opin Genet Dev; 2002 Feb; 12(1):86-91. PubMed ID: 11790560
[TBL] [Abstract][Full Text] [Related]
38. BRCA1 ubiquitinates RPB8 in response to DNA damage.
Wu W; Nishikawa H; Hayami R; Sato K; Honda A; Aratani S; Nakajima T; Fukuda M; Ohta T
Cancer Res; 2007 Feb; 67(3):951-8. PubMed ID: 17283126
[TBL] [Abstract][Full Text] [Related]
39. Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1.
Rodriguez JA; Schüchner S; Au WW; Fabbro M; Henderson BR
Oncogene; 2004 Mar; 23(10):1809-20. PubMed ID: 14647430
[TBL] [Abstract][Full Text] [Related]
40. BRCA1/BARD1 ubiquitinate phosphorylated RNA polymerase II.
Starita LM; Horwitz AA; Keogh MC; Ishioka C; Parvin JD; Chiba N
J Biol Chem; 2005 Jul; 280(26):24498-505. PubMed ID: 15886201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
